Table 2.
ATT regime | No. of respondents |
---|---|
2 HRZE+10 HR | 5 |
2 HRZE+10 HRE | 4 |
2 HRZE+7 HRE+9 HR | 1 |
3 HRZE+3 HRE+6 HR | 2 |
4 HRZE+5 HRE | 1 |
4 HRZE+14 HRE | 2 |
ATT, anti-tubercular treatment; H, isoniazid; R, rifampicin; Z, pyrazinamide; E, ethambutol.
ATT regime | No. of respondents |
---|---|
2 HRZE+10 HR | 5 |
2 HRZE+10 HRE | 4 |
2 HRZE+7 HRE+9 HR | 1 |
3 HRZE+3 HRE+6 HR | 2 |
4 HRZE+5 HRE | 1 |
4 HRZE+14 HRE | 2 |
ATT, anti-tubercular treatment; H, isoniazid; R, rifampicin; Z, pyrazinamide; E, ethambutol.